About
Team
Contact Us

A novel breakthrough in wrist-worn transdermal infrared sensor assessment for acute myocardial infarction

Carlsbad, California (March 19, 2023) – RCE Technologies, Inc.

ztad015 Download

About us

RCE.ai, an AI based med tech company works towards the early detection of heart attacks. We have re-imagined the way various biomarkers are monitored in the blood using a non-invasive transdermal technique. The AI enabled real-time cardiac assessment empowers emergency medicine physicians and cardiologists in the early assessment and appropriate risk stratification of patients presenting with chest pain. The company is currently conducting clinical studies and undertaking premarket efforts.

Address: 2292 Faraday Ave, #19, Carlsbad, CA 92008

INVESTOR RELATIONS: ir@rce.ai

MEDIA RELATIONS: pr@rce.ai

Latest posts

First-In-Human Transdermal Continuous Cardiac Biomarker Monitoring Showcased at the ACC.24
Groundbreaking Innovation Takes Center Stage: Winner Announced in Scientific Sessions 2023 Health Tech Competition
RCE presents late breaking findings at 2023 TCT Shark Tank
Editorial Review – Biomarkers Journal
Revolutionizing Medical Diagnostics: Innovations and Challenges

Remote Cardiac Enablement © 2024.

LinkedIn
X